November/December | 2010
Inside This Issue

Bookmark and Share

Gregory A. Yanik, M.D., actually didn't think medical school was a possibility until he ran into a friend who had taken the MCATs (the medical college admission test) and passed.

Gregory A. Yanik, M.D.With his typical warmth and good humor, Yanik says, "I hate to say it, but I thought, well, if my friend could do it, maybe I could, too."

Today, many people are very glad Dr. Yanik took those MCATs. He has had a direct impact with two groups of critically ill patients: those undergoing a bone marrow transplant and children with neuroblastoma.

As the Leland and Elaine Blatt Family Professor of Pediatric Hematology/Oncology, he has helped patients combat serious illnesses such as graft-versus-host disease, idiopathic pneumonia syndrome, acute myelogenous leukemia and the rare but deadly childhood cancer, neuroblastoma.

"Our goal is to not only find cures for the patients of today but for the patients of tomorrow," says Yanik, who is also a professor of Internal Medicine and of Pediatrics.

U-M has been leader in this field of research, having developed a tumor-specific scan called the MIBG scan in the 1980's to detect deadly neuroblastoma. MIBG scans are now used in virtually every children's hospital in the world.

Yanik's team has taken this research further, using MIBG not just as a method to diagnose neuroblastoma, but as a specific therapy for the disease. Over the past decade, U-M has treated patients from more than 32 states. And the therapy has proven so successful that it is now being considered for frontline (immediate) therapy for all patients with neuroblastoma, not just patients who have failed prior therapy.

He credits U-M's environment. "We're able to think outside the box," he says.

He notes that such thinking recently made it possible to establish a joint Pediatric/Adult Bone Marrow Transplant area to be located at the new Children's and Women's Hospital facility when it opens in late 2011.

The U-M Bone Marrow Transplant Program, headed by James Ferrara, M.D., was recently selected to be one of the Health System's new Destination Programs, and over the next two years will seek to increase the number of patients coming to U-M from long distances to receive transplants of bone marrow and peripheral stem cells.

"Our transplant program has been able to design novel research protocols to help transplant patients of all ages. It's been an incredible experience," Yanik says. "We are blessed with many good hospitals in the state of Michigan. These are all hospitals that can give high-quality care to patients when things are going well. However, there are only a few hospitals in the Midwest that can care for patients when things aren't going well, when their cancer has relapsed, or has failed other prior therapy."

"That's the Michigan difference, to be able to care for the toughest of cases, with the latest in therapy."

When not doing research or visiting patients, Yanik loves spending time with his three children and his wife Marybeth Yanik, an R.N. who recently joined the Comprehensive Cancer Center.


Comment on this article

"Great Article! Well Deserved!" Rajen Mody, Peds Oncology

"Greg Yanik is an outstanding physician. He is knowledgeble and exudes warmth and compassion for his patients. His research is innovative and bears directly on improving outcomes in patients with cancer." Laurence Boxer, Pediatrics


You may post my submission in future articles
Please share with editor only

Please fill out the following contact information. This information is required to process your request.
Your Name:
Your Department:
Your E-mail Address:
Your Work Phone Number:
 
Other Internal Publications:    Daily Bulletin    |    M-News Now!    |    Community Beat